HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Blood
; 139(10): 1452-1468, 2022 03 10.
Article
in En
| MEDLINE
| ID: mdl-34724567
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: